Yin‐Hsun Feng

机构：Chi Mei Medical Center · ORCID：0000-0002-8660-0685

发表论文 119 篇 · 总被引 3624 次 · h-index 25

代表论文

• Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study (2024 · Journal of Clinical Oncology · 被引 71)
• Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial (2024 · BMC Cancer · 被引 16)
• MDS-1497: Primary Analysis of the Randomized, Phase 3 VERONA Study of Venetoclax With Azacitidine Versus Placebo With Azacitidine in Patients With Treatment-Naïve, Intermediate and Higher-Risk Myelodysplastic Syndromes (2025 · Clinical Lymphoma Myeloma & Leukemia · 被引 14)
• Subgroup analyses from the randomized, Phase 3 VERONA study of venetoclax with azacitidine (Ven+Aza) versus placebo with azacitidine (Pbo+Aza) in patients with treatment-naïve, intermediate and higher-risk Myelodysplastic Syndromes (HR MDS) (2025 · Blood · 被引 6)
• Abstract CT226: Phase 2 study of oral CCR4 antagonist FLX475 (tivumecirnon) plus pembrolizumab in subjects with head and neck squamous cell carcinoma (HNSCC) previously treated with checkpoint inhibitor (2024 · Cancer Research · 被引 5)
• Exploring neuron-specific steroid synthesis and DHEAS therapy in Alzheimer's disease (2024 · The Journal of Steroid Biochemistry and Molecular Biology · 被引 4)